New genetic testing technology enhances precision of analysis of clinical biomarkers
Tuesday, December 18, 2018 - 08:21
in Biology & Nature
Scientists have announced the invention of a genetic testing technology that allows the number of clinical biomarkers to be analyzed at the single-molecule level, which enhances the sensitivity of tests in precision medicine and will make them more affordable in future. The TAC-seq method, for which a patent is pending, is already being used in fertility clinics to determine the personal variations in the menstrual cycle for opportune embryo transfer.